Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2014

01-01-2014 | Original Article

Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy

Authors: Zihui Tan, Guowei Ma, Jinming Zhao, Amos Ela Bella, Tiehua Rong, Jianhua Fu, Yuqi Meng, Kongjia Luo, Dongrong Situ, Peng Lin

Published in: Journal of Gastrointestinal Surgery | Issue 1/2014

Login to get access

Abstract

Background

To evaluate the feasibility and safety of recurrent laryngeal nerve (RLN) lymph node (LN) dissection, this study compared the postoperative complications and survival between modern two-field lymphadenectomy (MTL) and modified standard two-field lymphadenectomy (MSTL) by using the propensity score matching method.

Methods

After generating propensity scores given the covariates of age, sex, tumor length, tumor location, tumor grade, and clinical stage, 254 patients with MTL were matched to 254 MSTL patients using the nearest available score matching. The LNs resected during MSTL were paraesophageal and preparatracheal LNs in the upper mediastinum, in addition to those resected during standard two-field lymphadenectomy.

Results

RLN LNs were those most commonly affected by nodal metastasis in our series (26 %). Metastasis in RLN LNs was found in around 35, 25, and 20 % of patients with cancer in the upper, middle, and lower thoracic esophagus, respectively. LN metastasis was confined to the RLN region in 49 patients. Even 35 % of patients with pT1 tumors had positive RLN LNs. MTL increased the mean number of resected LNs when compared to MSTL (29 vs.15; p < 0.001). Recurrence was more frequent in those assigned MSTL than those assigned MTL (p < 0.001). The 5-year overall survival (OS) and disease-free survival (DFS) rate for MTL were 50.7 and 42 % compared to 35.3 and 28.2 % for MSTL (both p < 0.001), respectively. Postoperative complications were more frequent following MTL when compared to the MSTL. However, no statistically significant difference in postoperative complications was observed between the two groups.

Conclusions

Adding the removal of RLN LNs might improve OS and DFS with acceptable morbidity for patients with ESCC.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69–90.PubMedCrossRef Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011; 61(2): 69–90.PubMedCrossRef
2.
go back to reference Jamieson GG, Lamb PJ, Thompson SK, et al. The role of lymphadenectomy in esophageal cancer. Ann Surg, 2009; 250(2): 206–9.PubMedCrossRef Jamieson GG, Lamb PJ, Thompson SK, et al. The role of lymphadenectomy in esophageal cancer. Ann Surg, 2009; 250(2): 206–9.PubMedCrossRef
3.
go back to reference Akiyama H, Tsurumaru, M, Udagawa, H, Kajiyama, Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994; 220(3): 364–72.PubMedCrossRef Akiyama H, Tsurumaru, M, Udagawa, H, Kajiyama, Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg, 1994; 220(3): 364–72.PubMedCrossRef
4.
go back to reference Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg, 2004; 240(6): 962–72.PubMedCrossRef Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg, 2004; 240(6): 962–72.PubMedCrossRef
5.
go back to reference Nozoe T, Kakeji Y, Baba H, Maehara, Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus, 2005; 18(4): 226–9.PubMedCrossRef Nozoe T, Kakeji Y, Baba H, Maehara, Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus, 2005; 18(4): 226–9.PubMedCrossRef
6.
go back to reference Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg, 1995; 222(5): 654–62.PubMedCrossRef Fujita H, Kakegawa T, Yamana H, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg, 1995; 222(5): 654–62.PubMedCrossRef
7.
go back to reference Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg, 1994; 18(2): 266–72.PubMedCrossRef Fujita H, Kakegawa T, Yamana H, et al. Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection. World J Surg, 1994; 18(2): 266–72.PubMedCrossRef
8.
go back to reference Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus, 2001; 14(3–4): 191–6.PubMedCrossRef Shiozaki H, Yano M, Tsujinaka T, et al. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus, 2001; 14(3–4): 191–6.PubMedCrossRef
9.
go back to reference Tabira Y, Yasunaga M, Tanaka M, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg, 2000; 191(3): 232–7.PubMedCrossRef Tabira Y, Yasunaga M, Tanaka M, et al. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg, 2000; 191(3): 232–7.PubMedCrossRef
10.
go back to reference D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–81PubMedCrossRef D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–81PubMedCrossRef
11.
go back to reference Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33–38. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39: 33–38.
12.
go back to reference Edge SB, Byrd DR, Compton CC , et al. American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. Chicago: Springer, Inc; 2010. Edge SB, Byrd DR, Compton CC , et al. American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. Chicago: Springer, Inc; 2010.
13.
go back to reference Akiyama H, et al. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins, 1990: 19–42. Akiyama H, et al. Surgery for Cancer of the Esophagus. Baltimore: Williams & Wilkins, 1990: 19–42.
14.
go back to reference Bumm R, Wong J. More or less surgery for esophageal cancer: extent of lymphadenectomy for squamous cell esophageal carcinoma-How much is necessary? Dis Esophagus. 1994; 7 (3):151–55 Bumm R, Wong J. More or less surgery for esophageal cancer: extent of lymphadenectomy for squamous cell esophageal carcinoma-How much is necessary? Dis Esophagus. 1994; 7 (3):151–55
15.
go back to reference Shiraha S. Experimental studies on the lymphatics of the esophagus from the surgical point of view. Nihon Geka Hokan, 1969; 38(4): 543–64.PubMed Shiraha S. Experimental studies on the lymphatics of the esophagus from the surgical point of view. Nihon Geka Hokan, 1969; 38(4): 543–64.PubMed
16.
go back to reference Kuge K, Murakami G, Mizobuchi S, Hata, Y, Aikou, T, Sasaguri, S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003; 125(6): 1343–9.PubMedCrossRef Kuge K, Murakami G, Mizobuchi S, Hata, Y, Aikou, T, Sasaguri, S. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg, 2003; 125(6): 1343–9.PubMedCrossRef
17.
go back to reference Fujita H, Sueyoshi S, Tanaka T,Shirouzu K. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg, 2002; 8(6): 328–35.PubMed Fujita H, Sueyoshi S, Tanaka T,Shirouzu K. Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg, 2002; 8(6): 328–35.PubMed
18.
go back to reference Altorki NK, Zhou, X K, Stiles, B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg, 2008; 248(2): 221–6.PubMedCrossRef Altorki NK, Zhou, X K, Stiles, B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg, 2008; 248(2): 221–6.PubMedCrossRef
19.
go back to reference Stiles BM, Nasar Abu, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. European Journal of Cardio-Thoracic Surgery, 2012; 42 (4):659–64.PubMedCrossRef Stiles BM, Nasar Abu, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. European Journal of Cardio-Thoracic Surgery, 2012; 42 (4):659–64.PubMedCrossRef
20.
go back to reference Isono K, Onoda S, Okuyama, K, Sato, H. Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol, 1985; 15(1):49–60.PubMed Isono K, Onoda S, Okuyama, K, Sato, H. Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol, 1985; 15(1):49–60.PubMed
21.
go back to reference Malassagne B, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997; 185(3): 244–9.PubMed Malassagne B, et al. Prognostic value of thoracic recurrent nerve nodal involvement in esophageal squamous cell carcinoma. J Am Coll Surg, 1997; 185(3): 244–9.PubMed
Metadata
Title
Impact of Thoracic Recurrent Laryngeal Node Dissection: 508 Patients with Tri-Incisional Esophagectomy
Authors
Zihui Tan
Guowei Ma
Jinming Zhao
Amos Ela Bella
Tiehua Rong
Jianhua Fu
Yuqi Meng
Kongjia Luo
Dongrong Situ
Peng Lin
Publication date
01-01-2014
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 1/2014
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2411-2

Other articles of this Issue 1/2014

Journal of Gastrointestinal Surgery 1/2014 Go to the issue